Join Our Guests Camilla Graham MD Ri-CoDIFy: Ridinilazole’s Phase 3 Trial for the Treatment of C. difficile and Reduction of Recurrence. . Dr.Camilla S. Graham is Vice President and Chief Clinical Information Officer at Summit Therapeutics as well as a staff physician at Beth Israel Deaconess Medical Center in Boston, MA, and on faculty at Harvard Medical School.
Guest: Alba Muhlfeld, C. diff. Survivor - Sharing her C. diff. infection journey.
Guest: Erik Dubburke, MD, MSPH discusses
“Optimizing Prevention of Hospital-Onset Clostridioides difficile infection.”
Dr. Erik Dubberke is an Associate Professor of Medicine at Washington University School of Medicine in St. Louis, where he has been a faculty member in the Division of Infectious Diseases since 2005. He is an Associate Hospital Epidemiologist at Barnes-Jewish Hospital,
Presentations delivered live during the November 14th, 2020
8th Annual International C. diff. Conference & Health EXPO